80 related articles for article (PubMed ID: 16777966)
1. Chlamydial ribonucleotide reductase: tyrosyl radical function in catalysis replaced by the FeIII-FeIV cluster.
Voevodskaya N; Narvaez AJ; Domkin V; Torrents E; Thelander L; Gräslund A
Proc Natl Acad Sci U S A; 2006 Jun; 103(26):9850-4. PubMed ID: 16777966
[TBL] [Abstract][Full Text] [Related]
2. Radical-translocation intermediates and hurdling of pathway defects in "super-oxidized" (Mn(IV)/Fe(IV)) Chlamydia trachomatis ribonucleotide reductase.
Dassama LM; Jiang W; Varano PT; Pandelia ME; Conner DA; Xie J; Bollinger JM; Krebs C
J Am Chem Soc; 2012 Dec; 134(50):20498-506. PubMed ID: 23157728
[TBL] [Abstract][Full Text] [Related]
3. EXAFS simulation refinement based on broken-symmetry DFT geometries for the Mn(IV)-Fe(III) center of class I RNR from Chlamydia trachomatis.
Luber S; Leung S; Herrmann C; Du WH; Noodleman L; Batista VS
Dalton Trans; 2014 Jan; 43(2):576-83. PubMed ID: 24129440
[TBL] [Abstract][Full Text] [Related]
4. The active form of Chlamydia trachomatis ribonucleotide reductase R2 protein contains a heterodinuclear Mn(IV)/Fe(III) cluster with S = 1 ground state.
Jiang W; Bollinger JM; Krebs C
J Am Chem Soc; 2007 Jun; 129(24):7504-5. PubMed ID: 17530854
[TBL] [Abstract][Full Text] [Related]
5. Density functional theory analysis of structure, energetics, and spectroscopy for the Mn-Fe active site of Chlamydia trachomatis ribonucleotide reductase in four oxidation states.
Han WG; Giammona DA; Bashford D; Noodleman L
Inorg Chem; 2010 Aug; 49(16):7266-81. PubMed ID: 20604534
[TBL] [Abstract][Full Text] [Related]
6. Spectroscopic and electronic structure studies of intermediate X in ribonucleotide reductase R2 and two variants: a description of the FeIV-oxo bond in the FeIII-O-FeIV dimer.
Mitić N; Clay MD; Saleh L; Bollinger JM; Solomon EI
J Am Chem Soc; 2007 Jul; 129(29):9049-65. PubMed ID: 17602477
[TBL] [Abstract][Full Text] [Related]
7. HF-EPR, Raman, UV/VIS light spectroscopic, and DFT studies of the ribonucleotide reductase R2 tyrosyl radical from Epstein-Barr virus.
Tomter AB; Zoppellaro G; Schmitzberger F; Andersen NH; Barra AL; Engman H; Nordlund P; Andersson KK
PLoS One; 2011; 6(9):e25022. PubMed ID: 21980375
[TBL] [Abstract][Full Text] [Related]
8. DFT calculations for intermediate and active states of the diiron center with a tryptophan or tyrosine radical in Escherichia coli ribonucleotide reductase.
Han WG; Noodleman L
Inorg Chem; 2011 Mar; 50(6):2302-20. PubMed ID: 21322584
[TBL] [Abstract][Full Text] [Related]
9. Mössbauer properties of the diferric cluster and the differential iron(II)-binding affinity of the iron sites in protein R2 of class Ia Escherichia coli ribonucleotide reductase: a DFT/electrostatics study.
Han WG; Sandala GM; Giammona DA; Bashford D; Noodleman L
Dalton Trans; 2011 Nov; 40(42):11164-75. PubMed ID: 21837345
[TBL] [Abstract][Full Text] [Related]
10. Two-Color Valence-to-Core X-ray Emission Spectroscopy Tracks Cofactor Protonation State in a Class I Ribonucleotide Reductase.
Martinie RJ; Blaesi EJ; Bollinger JM; Krebs C; Finkelstein KD; Pollock CJ
Angew Chem Int Ed Engl; 2018 Sep; 57(39):12754-12758. PubMed ID: 30075052
[TBL] [Abstract][Full Text] [Related]
11. DFT calculations of comparative energetics and ENDOR/Mössbauer properties for two protonation states of the iron dimer cluster of ribonucleotide reductase intermediate X.
Han WG; Noodleman L
Dalton Trans; 2009 Aug; (30):6045-57. PubMed ID: 19623405
[TBL] [Abstract][Full Text] [Related]
12. Structure of a ribonucleotide reductase R2 protein radical.
Lebrette H; Srinivas V; John J; Aurelius O; Kumar R; Lundin D; Brewster AS; Bhowmick A; Sirohiwal A; Kim IS; Gul S; Pham C; Sutherlin KD; Simon P; Butryn A; Aller P; Orville AM; Fuller FD; Alonso-Mori R; Batyuk A; Sauter NK; Yachandra VK; Yano J; Kaila VRI; Sjöberg BM; Kern J; Roos K; Högbom M
Science; 2023 Oct; 382(6666):109-113. PubMed ID: 37797025
[TBL] [Abstract][Full Text] [Related]
13. A Mycobacterium tuberculosis ligand-binding Mn/Fe protein reveals a new cofactor in a remodeled R2-protein scaffold.
Andersson CS; Högbom M
Proc Natl Acad Sci U S A; 2009 Apr; 106(14):5633-8. PubMed ID: 19321420
[TBL] [Abstract][Full Text] [Related]
14. Theoretical Insights into the Generation Mechanism of the Tyr
Liu N; Li L; Qin X; Li X; Xie Y; Chen X; Gao J
Inorg Chem; 2023 Dec; 62(48):19498-19506. PubMed ID: 37987809
[TBL] [Abstract][Full Text] [Related]
15. Composition and Structure of the Inorganic Core of Relaxed Intermediate X(Y122F) of Escherichia coli Ribonucleotide Reductase.
Doan PE; Shanmugam M; Stubbe J; Hoffman BM
J Am Chem Soc; 2015 Dec; 137(49):15558-66. PubMed ID: 26636616
[TBL] [Abstract][Full Text] [Related]
16. A docking model of human ribonucleotide reductase with flavin and phenosafranine.
Priya PL; Shanmughavel P
Bioinformation; 2009 Sep; 4(3):123-6. PubMed ID: 20198185
[TBL] [Abstract][Full Text] [Related]
17. Iron Chelator Transmetalative Approach to Inhibit Human Ribonucleotide Reductase.
Gaur K; Pérez Otero SC; Benjamín-Rivera JA; Rodríguez I; Loza-Rosas SA; Vázquez Salgado AM; Akam EA; Hernández-Matias L; Sharma RK; Alicea N; Kowaleff M; Washington AV; Astashkin AV; Tomat E; Tinoco AD
JACS Au; 2021 Jun; 1(6):865-878. PubMed ID: 34240081
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of the C5 stereoinversion reaction in the biosynthesis of carbapenem antibiotics.
Chang WC; Guo Y; Wang C; Butch SE; Rosenzweig AC; Boal AK; Krebs C; Bollinger JM
Science; 2014 Mar; 343(6175):1140-4. PubMed ID: 24604200
[TBL] [Abstract][Full Text] [Related]
19. Ether cross-link formation in the R2-like ligand-binding oxidase.
Griese JJ; Branca RMM; Srinivas V; Högbom M
J Biol Inorg Chem; 2018 Aug; 23(6):879-886. PubMed ID: 29946980
[TBL] [Abstract][Full Text] [Related]
20. The origin and evolution of ribonucleotide reduction.
Lundin D; Berggren G; Logan DT; Sjöberg BM
Life (Basel); 2015 Feb; 5(1):604-36. PubMed ID: 25734234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
